Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05729347 · ClinicalTrials.gov registry record · NA
Treatment of Parental Anxiety Virtual Reality (VR)
A NA study of Anxiety and Virtual Reality, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 485
- Enrollment target
- 1
- Study location
NCT05729347: Completed NA study of Anxiety and Virtual Reality, sponsored by Stanford University.
NCT05729347 is a NA study of Anxiety and Virtual Reality that has completed, run by Stanford University. The registered enrollment target is 485 participants, above the 439-participant average among 364 other Anxiety trials with a reported enrollment target (10% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05729347, a NA study of Anxiety and Virtual Reality, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 485 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if non-invasive distracting devices (Virtual Reality headset) are more effective than the standard of care (i.e., no technology based distraction) for preventing anxiety in parental and pediatric populations
Primary Outcome
Anxiety level measured by a Visual Analogue Scale - Anxiety (VAS-A) ranging from 0-10. Scale ranges from 0-10, with higher scores indicating higher anxiety levels. Assessed in participants enrolled in both general hospital setting and specifically in the Emergency Department setting.
Conditions Studied
Interventions
- BEHAVIORAL Virtual Reality headset with calming scenery
Study Locations (1)
California
- Lucile Parkard Children's Hospital - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 485 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2025-10-13 |
| Phase | NA |
What the finished NCT05729347 record still lists
NCT05729347 is an interventional study that assigns participants to a tested intervention. The registered 485 participants enrollment target is mid-sized for trials with a published cap, above the 439-participant average among 364 other Anxiety trials with a reported enrollment target (10% higher).
The record links to 3 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Virtual Reality headset with calming scenery is the first listed.
NCT05729347 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05729347 about?
NCT05729347 is a clinical study titled "Treatment of Parental Anxiety Virtual Reality (VR)". The purpose of this study is to determine if non-invasive distracting devices (Virtual Reality headset) are more effective than the standard of care (i.e., no technology based distraction) for preventing anxiety in parental and pediatric populations
What is the current status of trial NCT05729347?
This trial is currently completed. It is a NA study. The enrollment target is 485 participants. The study started on 2023-06-01. Estimated completion is 2025-10-13.
What conditions does trial NCT05729347 study?
This clinical trial studies the following conditions: Anxiety, Virtual Reality, Parents.
What interventions are being tested in trial NCT05729347?
The interventions under investigation include: Virtual Reality headset with calming scenery (BEHAVIORAL).
Who is sponsoring clinical trial NCT05729347?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05729347 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05729347's enrollment target sits among peer trials
485 38th of 364 higher than 327 of 364 other Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07124910 · 485 participants · Phase 3
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
- NCT06420531 · 486 participants · NA
Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial
- NCT07097142 · 486 participants · Phase 3
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- NCT05421741 · 484 participants · Phase 4
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI